about
Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptabilityIn vitro and in vivo characterization of [3H]CNS-5161--a use-dependent ligand for the N-methyl-D-aspartate receptor in rat brain.D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window.Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury.A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke.Lubeluzole for acute ischaemic stroke.gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia.Current status of neuroprotective agents in the treatment of acute ischemic stroke.Neuroprotective effects of bovine colostrum on intracerebral hemorrhage-induced apoptotic neuronal cell death in rats.Magnesium in stroke treatment.Neuroprotective agents for the treatment of acute ischemic stroke.Treatments for stroke.A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of strokeMechanisms of ischemic brain injury.Clinical trials for cytoprotection in stroke.Gap junctions and hemichannels: communicating cell death in neurodevelopment and diseaseExperimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin.Genetic susceptibility to inflammatory injury and various adverse outcomesThe contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemiaThe glycine deportation system and its pharmacological consequences.Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function.The mechanisms of brain ischemic insult and potential protective interventions.Secondary Hematoma Expansion and Perihemorrhagic Edema after Intracerebral Hemorrhage: From Bench Work to Practical Aspects.Organic catatonia: a review.Ion channels involved in stroke.Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway.Analysis of a gene encoding two glycine transporter variants reveals alternative promoter usage and a novel gene structure.Trafermin for stroke recovery: is it time for another randomized clinical trial?Conotoxins: Therapeutic Potential and Application.Homeostasis of the Intraparenchymal-Blood Glutamate Concentration Gradient: Maintenance, Imbalance, and Regulation.The role of TRPM2 channels in neurons, glial cells and the blood-brain barrier in cerebral ischemia and hypoxia.Pharmacological approaches to the treatment and prevention of aphasia
P2860
Q26796447-38EF7366-E7A5-4A60-BD10-638344396A71Q33390132-788A8AFE-9C58-429D-B37E-6201BE46A3EEQ33615809-B21B47BB-8088-4F25-BCD3-F23C4B48CB4FQ33984607-3D845D5C-4ECF-434E-8F7B-E49B5674D45CQ33995061-A3C75AF5-6735-4B5C-BD4E-41435A87C3ABQ34116281-12975B06-97E0-4C88-87CC-40DB8D4824C7Q34216896-93F4545A-3F61-4F71-B715-A85BD2F0C755Q34566325-D2B24D01-C874-445C-9C44-A98B3928C74CQ34997656-15D57C94-0DEC-4EE3-81B9-001EE4D14AC2Q35032195-5C187EA3-57B7-482A-8EC6-D0658B0C1464Q35036473-A01D9C10-4336-4B6C-B06B-83AD2E090C2DQ35581150-CD576440-8BDD-45E2-8967-00AF9DDEE298Q35588323-6DAED6FE-317F-41BE-A8CE-362B619C2009Q35647414-E950486E-B034-4544-8277-819E2EC42BEFQ36045223-A03C28DC-FFE5-4051-9C83-B0C0F2CC7BAFQ36260714-2544D40D-C113-49C5-8E50-E1AC8953C91CQ36302081-434FDDF2-0269-41E3-9684-D16F348AFC1BQ36374968-BF8B70FB-EE86-4551-B93C-7F8FD8461BB0Q36690082-B1219F57-0705-4E88-AF19-673E99CBBFD1Q36880287-45A5E106-764E-4358-ADA7-8CE4D3785ECBQ36883430-C2DBBC40-22E6-4DFF-A735-36EFDD536A10Q37186180-6D29B39F-4462-4021-BD7B-FC92647BD682Q37485957-10727325-993F-4429-9DAD-67EBF6291688Q37740548-58E49733-602C-4CEC-8D4F-1CCC6D348D41Q37853392-C76EEE96-07A4-43C2-8378-80704BB7896EQ40408915-ADBEF81B-8780-4E93-9D92-66A0184A03FCQ41181860-FB1B422D-592A-4855-8DE4-9761589B2CF7Q42462887-28611BC0-0F2A-4A30-A9FB-39FC1380893CQ42614796-18C0D890-EACB-4C7B-9099-8BEB1C984D07Q46364124-CE03D7B9-0589-4996-8673-3B708502B6B1Q47119481-AF35AD10-B088-4D0F-8932-15F2985B80C6Q52354765-B7C3757B-4901-422B-BFD2-680E78E73FF1Q58255428-A8D078B9-605D-4180-9DF7-D17EBF22165C
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Cerestat and other NMDA antagonists in ischemic stroke.
@ast
Cerestat and other NMDA antagonists in ischemic stroke.
@en
Cerestat and other NMDA antagonists in ischemic stroke.
@nl
type
label
Cerestat and other NMDA antagonists in ischemic stroke.
@ast
Cerestat and other NMDA antagonists in ischemic stroke.
@en
Cerestat and other NMDA antagonists in ischemic stroke.
@nl
prefLabel
Cerestat and other NMDA antagonists in ischemic stroke.
@ast
Cerestat and other NMDA antagonists in ischemic stroke.
@en
Cerestat and other NMDA antagonists in ischemic stroke.
@nl
P1433
P1476
Cerestat and other NMDA antagonists in ischemic stroke.
@en
P2093
P356
10.1212/WNL.49.5_SUPPL_4.S66
P407
P433
P577
1997-11-01T00:00:00Z